LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | Mitoxantrone | 0.37 | uM | LJP6 | 3 | C22 | 72 | hr | 1235 | 1186 | 4156 | 0.2854 | -0.0169 |
MCF7 | MK2206 | 0.37 | uM | LJP6 | 1 | F04 | 72 | hr | 1235 | 1472 | 4156 | 0.3542 | 0.0810 |
MCF7 | MK2206 | 0.37 | uM | LJP6 | 2 | F04 | 72 | hr | 1235 | 1652 | 4156 | 0.3975 | 0.1426 |
MCF7 | MK2206 | 0.37 | uM | LJP6 | 3 | F04 | 72 | hr | 1235 | 1736 | 4156 | 0.4177 | 0.1714 |
MCF7 | Neratinib | 0.37 | uM | LJP5 | 1 | A16 | 72 | hr | 1235 | 2722 | 4156 | 0.6549 | 0.5090 |
MCF7 | Neratinib | 0.37 | uM | LJP5 | 2 | A16 | 72 | hr | 1235 | 2818 | 4156 | 0.6780 | 0.5419 |
MCF7 | Neratinib | 0.37 | uM | LJP5 | 3 | A16 | 72 | hr | 1235 | 2527 | 4156 | 0.6080 | 0.4422 |
MCF7 | Nilotinib | 0.37 | uM | LJP5 | 1 | N16 | 72 | hr | 1235 | 3762 | 4156 | 0.9052 | 0.8651 |
MCF7 | Nilotinib | 0.37 | uM | LJP5 | 2 | N16 | 72 | hr | 1235 | 4513 | 4156 | 1.0859 | 1.1222 |
MCF7 | Nilotinib | 0.37 | uM | LJP5 | 3 | N16 | 72 | hr | 1235 | 4495 | 4156 | 1.0815 | 1.1160 |
MCF7 | Nintedanib | 0.37 | uM | LJP6 | 1 | H04 | 72 | hr | 1235 | 2977 | 4156 | 0.7163 | 0.5963 |
MCF7 | Nintedanib | 0.37 | uM | LJP6 | 2 | H04 | 72 | hr | 1235 | 2577 | 4156 | 0.6200 | 0.4593 |
MCF7 | Nintedanib | 0.37 | uM | LJP6 | 3 | H04 | 72 | hr | 1235 | 2823 | 4156 | 0.6792 | 0.5436 |
MCF7 | NU7441 | 0.37 | uM | LJP5 | 1 | C10 | 72 | hr | 1235 | 4227 | 4156 | 1.0170 | 1.0243 |
MCF7 | NU7441 | 0.37 | uM | LJP5 | 2 | C10 | 72 | hr | 1235 | 4065 | 4156 | 0.9781 | 0.9688 |
MCF7 | NU7441 | 0.37 | uM | LJP5 | 3 | C10 | 72 | hr | 1235 | 4399 | 4156 | 1.0584 | 1.0831 |
MCF7 | Dactolisib | 0.37 | uM | LJP5 | 1 | M16 | 72 | hr | 1235 | 1534 | 4156 | 0.3691 | 0.1022 |
MCF7 | Dactolisib | 0.37 | uM | LJP5 | 2 | M16 | 72 | hr | 1235 | 1751 | 4156 | 0.4213 | 0.1765 |
MCF7 | Dactolisib | 0.37 | uM | LJP5 | 3 | M16 | 72 | hr | 1235 | 1752 | 4156 | 0.4215 | 0.1769 |
MCF7 | NVP-TAE684 | 0.37 | uM | LJP6 | 1 | K16 | 72 | hr | 1235 | 1228 | 4156 | 0.2955 | -0.0025 |
MCF7 | NVP-TAE684 | 0.37 | uM | LJP6 | 2 | K16 | 72 | hr | 1235 | 1154 | 4156 | 0.2777 | -0.0279 |
MCF7 | NVP-TAE684 | 0.37 | uM | LJP6 | 3 | K16 | 72 | hr | 1235 | 1206 | 4156 | 0.2902 | -0.0101 |
MCF7 | Palbociclib | 0.37 | uM | LJP6 | 1 | E16 | 72 | hr | 1235 | 1899 | 4156 | 0.4569 | 0.2272 |
MCF7 | Palbociclib | 0.37 | uM | LJP6 | 2 | E16 | 72 | hr | 1235 | 2338 | 4156 | 0.5625 | 0.3775 |
MCF7 | Palbociclib | 0.37 | uM | LJP6 | 3 | E16 | 72 | hr | 1235 | 2135 | 4156 | 0.5137 | 0.3080 |